Plante Moran Financial Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384 Buy
+17
New +$382 ﹤0.01% 1217
2019
Q1
– Sell
-28
Closed -$1K – 830
2018
Q4
$1K Buy
+28
New +$1.13K ﹤0.01% 794
2018
Q3
– Sell
-1,150
Closed -$58K – 786
2018
Q2
$58K Buy
1,150
+397
+53% +$20.1K 0.03% 301
2018
Q1
$38K Buy
753
+73
+11% +$3.89K 0.02% 405
2017
Q4
$36K Buy
+680
New +$33.8K 0.02% 406

Other funds holding FMS

Plante Moran Financial Advisors's FMS Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Fresenius Medical Care (FMS) in Q2 2026: 17 shares worth $384. The stake represents ﹤0.01% of the portfolio and ranks #1217 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in FMS as recently as Q4 2018.

Plante Moran Financial Advisors first reported a position in FMS in Q4 2017 and has held it in 5 quarters since. The position peaked at $58K in Q2 2018. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Plante Moran Financial Advisors held 17 shares of Fresenius Medical Care worth $384 as of Q2 2026.
  • Fresenius Medical Care was a new Plante Moran Financial Advisors position in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1217 holding.
  • Plante Moran Financial Advisors first reported a position in Fresenius Medical Care in Q4 2017 and has held it in 5 quarters since.
  • Plante Moran Financial Advisors's Fresenius Medical Care position peaked at $58K in Q2 2018.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.